CORD-19:cb16d307afaecebd683e6d74c8b501ed54b0c9a4 / 57524-57864 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T334","span":{"begin":0,"end":340},"obj":"Sentence"},{"id":"T68761","span":{"begin":0,"end":340},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The antihyperglycemic activity of pyrazolone derivatives was explored by Kees et al. [130] The potent compound 173 (100 mg/kg) (Fig. 18 ) caused a 68% decrease in plasma glucose in db/db mice, moreover, it essentially normalized the level of glucose at 20 mg/kg (57% reduction) and maintained remarkable reduction at 2 mg/kg (30% decrease)."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T48","span":{"begin":0,"end":340},"obj":"Sentence"}],"text":"The antihyperglycemic activity of pyrazolone derivatives was explored by Kees et al. [130] The potent compound 173 (100 mg/kg) (Fig. 18 ) caused a 68% decrease in plasma glucose in db/db mice, moreover, it essentially normalized the level of glucose at 20 mg/kg (57% reduction) and maintained remarkable reduction at 2 mg/kg (30% decrease)."}